Metabolomic profile of cerebrospinal fluid from patients with diffuse gliomas
CSF-metabolome profiling, unlike blood profiling, shows promise as a diagnostic tool for glioma patients with the potential to assign molecular subtypes. The next step will involve a larger multicenter study to validate these findings, with the ultimate objective of integrating CSF metabolomics analysis into clinical practice.
Authors
- Thomas Skripuletz (ORCID: https://orcid.org/0000-0001-8550-335X)
- Nora Möhn
- Christian Johannes Hartmann (ORCID: https://orcid.org/0009-0004-3700-3536)
- Sandra Nay (ORCID: https://orcid.org/0000-0002-4986-1181)
- Philipp Schwenkenbecher (ORCID: https://orcid.org/0000-0002-1260-1650)
- Hauke Thiesler (ORCID: https://orcid.org/0000-0001-5561-3988)
- Kerstin Schwabe (ORCID: https://orcid.org/0000-0002-2041-066X)
- Friedrich Feuerhake (ORCID: https://orcid.org/0000-0002-1234-982X)
- Herbert Hildebrandt (ORCID: https://orcid.org/0000-0002-1044-0881)
- Fadi Al-Tarawni
- Lea Grote‐Levi
- Sven Schuchardt (ORCID: https://orcid.org/0000-0002-4593-9324)
- Harold F. Hounchonou (ORCID: https://orcid.org/0000-0001-7976-7113)
- Joachim K. Krauss (ORCID: https://orcid.org/0000-0002-0675-9064)
- Majid Esmailezadeh
Institutions
- Medizinische Hochschule Hannover (DE)
- Fraunhofer Institute for Toxicology and Experimental Medicine (DE)
Publication Details
- Journal
- Journal of Neurology
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1007/s00415-024-12667-9
- Citations
- 5
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.43